Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1066-1074

  Arita, Minetaro ^a   Horie, Hitoshi ^b   Arita, Mineo ^c   Nomoto, Akio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Japan Poliomyelitis Research Institute   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G2A; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN CONFORMATION; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

EID: 0032944586     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1066-1074.1999     Document Type: Article

References (54)

1. Aoki, J., S. Koike, I. Ise, Y. Sato-Yoshida, and A. Nomoto. 1994. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J. Biol. Chem. 269:8431-8438.
2. Arita, M., S. Koike, J. Aoki, H. Horie, and A. Nomoto. 1998. Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J. Virol. 72:3578-3586.
3. Bernhardt, G., J. Harber, A. Zibert, M. deCrombrugghe, and E. Wimmer. 1994. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding. Virology 203:344-356.
4. Bouchard, M. J., and V. R. Racaniello. 1997. CD44 is not required for poliovirus replication. J. Virol. 71:2793-2798.
5. Curry, S., M. Chow, and J. M. Hogle. 1996. The poliovirus 135S particle is infectious, J. Virol. 70:7125-7131.
6. Davis, W., P. T. Harrison, M. J. Hutchinson, and J. M. Allen. 1995. Two distinct regions of FC gamma R1 initiate separate signalling pathways involved in endocytosis and phagocytosis. EMBO J. 14:432-441.
7. Dove, A. W., and V. R. Racaniello. 1997. Cold-adapted poliovirus mutants bypass a postentry replication block. J. Virol. 71:4728-4735.
8. Fox, M. P., M. J. Otto, and M. A. McKinlay. 1986 Prevention of rhinovirus and poliovirus uncoating by WIN 51711. a new antiviral drug. Antimicrob Agents Chemother 30:110-116.
9. Freistadt, M. S., and K. E. Eberle. 1996. CD44 is not required for poliovirus replication in cultured cells and does not limit replication in monocytes. Virology 224:542-547.
10. Fricks, C. E., and J. M. Hogle. 1990. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 64:1934-1945.
11. Greve, J. M., C. P. Forte, C. W. Marlor, A. M. Meyer, H. Hoover-Litty, D. Wunderlich, and A. McClelland. 1991. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J. Virol. 65:6015-6023.
12. Gromeier, M., and K. Wetz. 1990. Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment. J. Virol. 64:3590-3597.
13. Guttman, N., and D. Baltimore. 1977. A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay. Virology 82:25-36.
14. Harber, J., G. Bernhardt, H. H. Lu, J. Y. Sgro, and E. Wimmer. 1995. Canyon rim residues, including antigenic determinants, modulate serotypespecilic binding of polioviruses to mutants of the poliovirus receptor. Virology 214:559-570.
15. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 673. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
16. Hawkes, R. A. 1964. Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Aust. J. Exp. Biol. Med. Sci. 42:465-482.
17. Hawkes, R. A., and K. J. Lafferty. 1967. The enhancement of virus infectivity by antibody. Virology 33:250-261.
18. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358-1365.
19. Hoover-Litty, H., and J. M. Greve. 1993. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J. Virol. 67: 390-397.
20. Hulett, M. D., N. Osman, I. F. McKenzie, and P. M. Hogarth. 1991 Chimeric Fc rceptors identify functional domains of the murine high affinity receptor for IgG. J. Immunol. 147:1863-1868.
21. Inada, T., K. T. Chong, and C. A. Mims. 1985. Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J. Gen. Virol. 66:871-878.
22. Ismail-Cassim, N., C. Chezzi, and J. F. Newman. 1990. Inhibition of the uncoating of bovine enterovirus by short chain fatty acids. J. Gen. Virol. 71: 2283-2289.
23. Kaplan, G., M. S. Freistadt, and V. R. Racaniello. 1990. Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol. 64:4697-4702.
24. Kim, K. H., P. Willingmann, Z. X. Gong, M. J. Kremer, M. S. Chapman, I. Minor, M. A. Oliveira, M. G. Rossmann, K. Andries, G. D. Diana, F. J. Dutko, M. A. Mckinlay, and D. C. Pevear. 1993. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J. Mol. Biol. 230:206-227.
25. King, A. A., J. J. Sands, and J. S. Porterfield. 1984. Antibody-mediated enhancement of rabies virus infection in a mouse macrophage cell line (P388D1). J. Gen. Virol. 65:1091-1093.
26. Koike, S., H. Horie, I. Ise, A. Okitsu, M. Yoshida, N. Iizuka, K. Takeuchi, T. Takegami, and A. Nomoto. 1990. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:3217-3224.
27. Koike, S., I. Ise, and A. Nomoto. 1991. Functional domains of the poliovirus receptor. Proc. Natl. Acad. Sci. USA 88:4104-4108.
28. Lee, W. M., S. S. Monroe, and R. R. Rueckert. 1993. Role of maturation cleavage in infectivily of picornaviruses: activation of an infectosome. J. Virol. 67:2110-2122.
29. Lewis, J. K., B. Bothner, T. J. Smith, and G. Siuzdak. 1998. Antiviral agent blocks breathing of the common cold virus. Proc. Natl. Acad. Sci. USA 95: 6774-6778.
30. Lewis, V. A., T. Koch, H. Plutner, and I. Mellman. 1986. A complementary DNA clone for a macrophage-lymphocyte Fc receptor. Nature 324:372-375.
31. Li, Q., A. G. Yafal, Y. M. Lee, J. Hogle, and M. Chow. 1994. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J. Virol. 68:3965-3970.
32. Lonberg-Holm, K., L. B. Gosser, and J. C. Kauer. 1975. Early alteration of poliovirus in infected cells and its specific inhibition. J. Gen. Virol. 27:329-342.
33. Mason, P. W., B. Baxt, F. Brown, J. Barber, A. Murdin, and E. Wimmer. 1993. Antibody-complexed foot- and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 192:568-577.
34. Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865.
35. Miller, K. L., A. M. Duchemin, and C. L. Anderson. 1996. A novel role for the Fc receptor gamma subunit: enhancement of Fc gamma R ligand affinity. J. Exp. Med. 183:2227-2233.
36. Morrison, M. E., Y. J. He, M. W. Wien, J. M. Hogle, and V. R. Racaniello. 1994. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:2578-2588.
37. Pace, C. N., F. Vajdos, L. Fee, G. Grimsley, and T. Gray. 1995. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4:2411-2423.
38. Perez, L., and L. Carrasco. 1993. Entry of poliovirus into cells does not require a low-pH step. J. Virol. 67:4543-4548.
39. Porterfield, J. S. 1986. Antibody-dependent enhancement of viral infectivity. Adv. Virus Res. 31:335-355.
40. Ravetch, J. V., A. D. Luster, R. Weinshank, J. Kochan, A. Pavlovec, D. A. Portnoy, J. Hulmes, Y. C. Pan, and J. C. Unkeless. 1986. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science 234:718-725.
41. Rossmann, M. G., E. Arnold, J. W. Erickson, E. A. Frankenberger, J. P. Griffith, H. J. Hecht, J. E. Johnson, G. Kamer, M. Luo, A. G. Mosser, R. R. Rueckert, B. Sherry, and G. Vriend. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145-153.
42. Rueckert, R. R. 1996. Picornaviridae: the viruses and their replication, p. 609-654. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
43. Sears, D. W., N. Osman, B. Tate, I. F. McKenzie, and P. M. Hogarth. 1990. Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. J. lmmunol. 144:371-378.
44. Selinka, H. C, A. Zibert, and E. Wimmer. 1991. Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway. Proc. Natl. Acad. Sci. USA 88:3598-3602.
45. Shepard, D. A., B. A. Heinz, and R. R. Rueckert. 1993. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J. Virol. 67:2245-2254.
46. Shepley, M. P., and V. R. Racaniello. 1994. A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J. Virol. 68:1301-1308.
47. Shiroki, K., T. Ishii, T. Aoki, M. Kobashi, S. Ohka, and A. Nomoto. 1995. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J. Virol. 69:6825-6832.
48. Tosteson, M. T., and M. Chow. 1997. Characterization of the ion channels formed by poliovirus in planar lipid membranes. J. Virol. 71:507-511.
49. Unkeless, J. C., E. Scigliano, and V. H. Freedman. 1988. Structure and function of human and murine receptors for IgG. Annu. Rev. lmmunol. 6:251-281.
50. van de Winkel, J. G., and P. J. Capel. 1993. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. lmmunol. Today 14:215-221.
51. Weiss, R. C., and F. W. Scott. 1981. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. lmmunol. Microbiol. Infect. Dis. 4:175-189.
52. Yafal, A. G., G. Kaplan, V. R. Racaniello, and J. M. Hogle. 1993. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology 197:501-505.
53. Yang, W.-X., T. Terasaki, K. Shiroki, S. Ohka, J. Aoki, S. Tanabe, T. Nomura, E. Terada, Y. Sugiyama, and A. Nomoto. 1997. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229:421-428.
54. Zibert, A., H. C. Selinka, O. Elroy-Stein, and E. Wimmer. 1992. The soluble form of two N-terminal domains of the poliovirus receptor is sufficient for blocking viral infection. Virus Res. 25:51-61.